Author:
Li Shunrong,Zhang Songliang,Zhang Xiaolan,Yan Jingwen,Wang Shuai,Tan Luyuan,Rao Nanyan,Chen Kai,Zhu Liling
Abstract
Abstract
Background
Breast cancer surgeries involving MS-TRAM/DIEP breast reconstruction has traditionally been collaborative efforts between breast surgeons and plastic surgeons. However, in our institution, this procedure is performed by dual-trained breast surgeons who are proficient in both breast surgery and MS-TRAM/DIEP breast reconstruction. This study aims to provide insights into the learning curve associated with this surgical approach.
Materials and methods
We included eligible breast cancer patients who underwent MS-TRAM/DIEP breast reconstruction by dual-trained breast surgeons between 2015 and 2020 at our institution. We present the learning curve of this surgical approach, with a focus on determining factors affecting flap harvesting time, surgery time, and ischemic time. Additionally, we assessed the surgical complication rates.
Results
A total of 147 eligible patients were enrolled in this study. Notably, after 30 cases, a statistically significant reduction of 1.7 h in surgery time and 21 min in ischemic time was achieved, signifying the attainment of a plateau in the learning curve. And the major and minor complications were comparable between the early and after 30 cases.
Conclusion
This study explores the learning curve and feasibility experienced by dual-trained breast surgeons in performing MS-TRAM/DIEP breast reconstruction.
Trial registration
NCT05560633.
Funder
Guangdong Science and Technology Department
National Natural Science Foundation of China
the Yat-sen Scholarship of Young Scientist program of Sun Yat-sen Memorial Hospital, the Sun Yat-sen Clinical Research Cultivating Program of Sun Yat-sen Memorial Hospital
Guangdong Provincial Development and Reform Commission
the Guangzhou Science Technology and Innovation Commission
the Sun Yat-Sen University Clinical Research 5010 Program
the National Institute of Hospital Administration
the China Anti-aging Promoting Association
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Ouyang Q, Zhu L, Chen K, Su F. Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients. PLoS ONE. 2015;10(2):e0118161.
2. Huang NS, Wu J. Nipple-sparing mastectomy in breast Cancer: from an oncologic safety perspective. Chin Med J (Engl). 2015;128(16):2256–61.
3. Mota BS, Riera R, Ricci MD, Barrett J, de Castria TB, Atallah AN, Bevilacqua JL. Nipple- and areola-sparing mastectomy for the treatment of breast cancer. Cochrane Database Syst Rev. 2016;11:CD008932.
4. Galimberti V, Vicini E, Corso G, Morigi C, Fontana S, Sacchini V, Veronesi P. Nipple-sparing and skin-sparing mastectomy: review of aims, oncological safety and contraindications. Breast. 2017;34(Suppl 1):82–S84.
5. Fujimoto H, Ishikawa T, Satake T, Ko S, Shimizu D, Narui K, Yamada A, Sasaki T, Nagashima T, Endo I, et al. Donor site selection and clinical outcomes of nipple-areola skin-sparing mastectomy with immediate autologous free flap reconstruction: a single-institution experience. Eur J Surg Oncol. 2016;42(3):369–75.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献